c-myc Amplification in hepatocellular carcinoma predicts unfavorable prognosis

Modern Pathology

Volumn 9, Issue 2, 1996, Pages 95-98

  Abou Elella, Ashraf ^a   Gramlich, Terry ^a   Fritsch, Christine ^a   Gansler, Ted ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

c myc; Hepatocellular carcinoma; Oncogene

Indexed keywords

MYC PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0029874206     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Craig JR, Peters RL, Edmondson HA: Tumors of the liver and intrahepatic bile ducts. Washington DC, Armed Forces Institute of Pathology, 1989.
2. Lotze MT, Flickinger JC, Carr B: Hepatobiliary neoplasms. In Cancer: Principles and Practice of Oncology, Fourth Edition, edited by DeVita VT, Hellman S, Rosenberg SA, p 883. Philadelphia, JB Lippincott, 1993
3. Joseph FB, Baumgarten DA, Bernardino ME: Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress. Radiology 186: 553, 1993
4. Pichlmayr R, Weimann A, Ringe B: Indications for liver transplantation in hepatobiliary malignancy. Hepatology 20(Suppl):33S, 1994
5. Borg A, Boldertorp B, Ferno M, Olsson H, Siffurdson H: c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int J Cancer 51:687, 1992
6. Berns EMJJ, Klign JGM, van Putten WLJ, vanStaveren IL, Portengen H, Foekens JA: c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 52:1107, 1992
7. Seeger RC, Brodeur GM, Sather H, et al.: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111, 1985
8. Slamon DJ, Godolphin W, Jones LA, et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:423, 1987
9. Gramlich TL, Fritsch C, Maurer D, Eberle M, Gansler T: Differential polymerase chain reaction assay of cyclin D1 amplification in esophageal carcinoma. Diagn Mol Pathol 3:255, 1994
10. Perkins AS, Vande Woude GF: Principles of molecular cell biology of cancer: Oncogenes. In Cancer: Principles and Practice of Oncology, Fourth Edition, edited by DeVita VT, Hellman S, Rosenberg SA. p 35. Philadelphia, JB Lippincott, 1993
11. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B: Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233: 461, 1986
12. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79:7824, 1982
13. Sumegi J, Hedberg T, Bjorkholm M, et al.: Amplification of the c-myc oncogene in human plasma-cell leukemia. Int J Cancer 36: 367, 1985
14. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N: Sequential protooncogene expression during rat liver regeneration. Cancer Res 46:3111, 1986
15. Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA: Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci U S A 89:3874, 1992
16. Hansen LJ, Tennant BC, Seeger C, Ganem D: Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell Biol 13:659, 1993
17. Tabor E: Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42:357, 1994
18. Gan FY, Gesell MS, Alousi M, Luk GD: Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry. J Histochem Cytochem 4:1185, 1993
19. Arbuthnot P, Kew M, Fitschen W: c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 11: 921, 1991
20. Zhang XK, Huang DP, Qiu DK, Chiu JF: The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 5:909, 1990
21. Tiniakos D, Spandidos DA, Kakkanas A, Pintzas A, Pollice L, Tiniakos G: Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues. Anticancer Res 9:715, 1989
22. Peng SY, Lai PL, Hsu HC: Amplification of the c-myc gene in human hepatocellular carcinoma: Biologic significance. J Formos Med Assoc 92:866, 1993
23. Robinson WS: Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu Rev Med 1994; 45:297, 1994
24. Gramlich TL, Cohen C, Fritsch C, DeRose P, Gansler T: Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction. Am J Clin Pathol 101:493, 1994
25. Frye RA, Benz CC, Liu E: Detection of amplified oncogenes by differentaial polymerase chain reaction. Oncogene 4:1153, 1989
26. Engel H, de la Cruz ZC, Jimene-Abalhin LD, Green WR, Mechels RG: Cytopreparatory techniques for eye fluid specimens obtained by vitrectomy. Acta Cytol 26:551, 1982
27. Gramlich TL, Fritsch C, Shear S, Sgoutas D, Tuten T, Gansler T: Analysis of epidermal growth factor receptor gene expression in stained smears and formalin fixed paraffin-embedded cell pellets by reverse transcription intron differential polymerase chain reaction. Anal Quant Cytol Histol 15:317, 1993
28. Muller S, Vigneswaran N, Gansler TS, Gramlich T, DeRose P, Cohen C: c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: Relationship to prognosis. Mod Pathol 7:628, 1994